Corticosteroids infiltration

PreclinicalSmall molecule

CCentre Hospitalier Departemental Vendee

Corticosteroids infiltration is one of 8 small molecule programs targeting Arthropathy. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

ArthropathyActive, not recruiting

ArthropathyPreclinical

Active, not recruiting

Competition

Competitive Landscape

7 competitors in Arthropathy

#DrugCompanyPhaseTrials

Marinol

Enbrel

1 3

Vancocin

HHikma Pharmaceuticals LLC

Approved

—4

Naropin

FFresenius Kabi USA, LLC

Cyklokapron

Decadron

AAspen Global Incorporated

Preclinical

1 7

Antiviral Agents

MMahidol University

Preclinical

1 8

Corticosteroids infiltration

CCentre Hospitalier Departemental Vendee

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Arthropathy1 trial

Care of AcromioClavicular Arthropathy in Manual Medicine Versus Corticosteroid Infiltration (ACAM)

Terminated·—·N/A·NCT03951480·35 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Corticosteroids infiltration. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Corticosteroids infiltration compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Corticosteroids infiltration. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Centre Hospitalier Departemental Vendee company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: CCentre Hospitalier Departemental Vendee

Corticosteroids infiltration

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Arthropathy1 trial

References

Drug Info

Quick Facts

Related News